Open AccessSuccessful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance
Author(s) -
André Furco,
Bhairvi Gosrani,
Sara Nicholas,
Amanda Williams,
Wunmi Braithwaite,
Anton Pozniak,
Graham P. Taylor,
David Asboe,
Hermione Lyall,
Andrew J. Shaw,
Moses Kapembwa
Publication year - 2009
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32832027d6
Subject(s) - emtricitabine , darunavir , nevirapine , etravirine , efavirenz , lamivudine , virology , didanosine , enfuvirtide , medicine , ritonavir , atazanavir , zidovudine , lopinavir , nelfinavir , resistance mutation , reverse transcriptase inhibitor , pharmacology , viral load , reverse transcriptase , biology , immunology , virus , viral disease , gp41 , hepatitis b virus , polymerase chain reaction , antiretroviral therapy , antigen , epitope , biochemistry , gene